Nexplanon Observational Risk Assessment Study (NORA)

Trial Profile

Nexplanon Observational Risk Assessment Study (NORA)

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 09 Jan 2015

At a glance

  • Drugs Etonogestrel (Primary)
  • Indications Pregnancy
  • Focus Adverse reactions
  • Acronyms NORA
  • Most Recent Events

    • 06 Jan 2015 Status changed from recruiting to active, no longer recruiting, as reported by ClinicalTrials.gov.
    • 02 Dec 2013 Planned end date (1 Oct 2017) added as reported by ClinicalTrials.gov.
    • 22 Nov 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top